KOVALTRY®, Antihemophilic Factor (Recombinant), is a recombinant,
human DNA sequence derived, full length Factor VIII concentrate indicated
for use in adults and children with hemophilia A (congenital Factor VIII
deficiency) for:
On-demand treatment and control of bleeding episodes
Perioperative management of bleeding
Routine prophylaxis to reduce the frequency of bleeding episodes
via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2nxbn80
No comments:
Post a Comment